Filing Flows › Mirum Pharmaceuticals (MIRM) › Capital expenditures
Mirum Pharmaceuticals (MIRM) capital expenditures by quarter
Mirum Pharmaceuticals' capital expenditures were $600K in Q4 2025 (fourth quarter 2025), +221% from Q3 2025. Over the last 3 quarters it ranged from $126K (Q2 2025) to $600K (Q4 2025).
| Quarter | Capital expenditures | Q/Q | Y/Y |
|---|---|---|---|
| Q4 2025 | $600K | +221% | — |
| Q3 2025 | $187K | +48% | — |
| Q2 2025 | $126K | — | — |
Q4 2025 at a glance
Mirum Pharmaceuticals, Q4 2025: revenue $149M (+50% year over year), operating margin -3.1%, net loss $5.7M, operating cash flow $6.1M. The chart follows the revenue to costs, profit and cash.
Questions
What is Mirum Pharmaceuticals' capital expenditures?
Mirum Pharmaceuticals' capital expenditures were $600K in Q4 2025 (fourth quarter 2025), +221% from Q3 2025.
How has Mirum Pharmaceuticals' capital expenditures changed?
Over the last 3 quarters it ranged from $126K (Q2 2025) to $600K (Q4 2025).